Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Cartherics CEO Alan Trounson celebrates 40 years of the GSK Award for Excellence
By Christine Filippis / September 8, 2020
Along with others Alan shares his experience in this short clip ......... https://twitter.com/i/status/1300993040199217152
Read More
The answer to self-discovery is found at Cartherics
By Christine Filippis / September 2, 2020
For new recruit Walid Azar, it was about finding his calling. As Walid Azar settles into his new dual role...
Read More
‘Chance favours the prepared mind’
By Christine Filippis / August 27, 2020
Frederico Calhabeu has followed Louis Pasteur’s advice from France to Cartherics By Leigh Dayton When considering whether to continue his...
Read More
